Medical comorbidity of binge eating disorder
- 1.1k Downloads
To gain further understanding of the general medical comorbidity of binge eating disorder (BED) beyond its association with obesity.
We reviewed studies of general medical comorbidity in people with BED or clinically significant binge eating behavior beyond obesity. We also reviewed studies of BED in specific medical conditions.
Three broad study categories of medical comorbidity in BED were found: cross-sectional studies of medical conditions in BED; prospective studies of medical conditions in BED; and studies of BED in specific medical conditions. Cross-sectional epidemiologic data suggest that BED is associated with medical conditions related to obesity, including diabetes, hypertension, dyslipidemias, sleep problems/disorders, and pain conditions, and that BED may be related to these conditions independent of obesity and co-occurring psychiatric disorders. Prospective data suggest that BED may be associated with type 2 diabetes and metabolic syndrome. BED or binge eating behavior is also associated with asthma and gastrointestinal symptoms and disorders, and among women, menstrual dysfunction, pregnancy complications, intracranial hypertension, and polycystic ovary syndrome.
BED is associated with substantial medical comorbidity beyond obesity. Further study of the general medical comorbidity of BED and its relationship to obesity and co-occurring psychiatric disorders is greatly needed.
KeywordsBinge eating Medical comorbidity Obesity Diabetes Metabolic syndrome
Compliance with ethical standards
This study received no funding.
Conflict of interest
Drs. Olguin, Fuentes and Gabler have no conflicts of interest to disclose. Dr. McElroy is a consultant to or member of the scientific advisory boards of Bracket, F. Hoffmann-La Roche Ltd., MedAvante, Myriad, Naurex, Novo Nordisk, Shire, and Sunovion. She is a principal or co-investigator on studies sponsored by the Alkermes, Forest, Marriott Foundation, National Institute of Mental Health, Naurex, Orexigen Therapeutics, Inc., Shire, Sunovion, and Takeda Pharmaceutical Company Ltd. She is also an inventor on United States Patent No. 6,323,236 B2, Use of Sulfamate Derivatives for Treating Impulse Control Disorders, and along with the patent’s assignee, the University of Cincinnati, Cincinnati, Ohio, has received payments from Johnson & Johnson, which has exclusive rights under the patent. Dr. Keck is employed by the University of Cincinnati College of Medicine and the University of Cincinnati Physicians. Dr. Keck is presently or has been in the past year a principal or co-investigator on research studies sponsored by: Cephalon, Marriott Foundation, National Institute of Mental Health (NIMH), Shire. Dr. Keck has been reimbursed for consulting to: 2014: Shire, Supernus, Otsuka, ProPhase, Merck. Dr. Paul E. Keck, Jr. is a co-inventor on United States Patent No. 6,387,956: Shapira NA, Goldsmith TD, Keck, PE Jr. (University of Cincinnati) Methods of treating obsessive–compulsive spectrum disorder comprises the step of administering an effective amount of tramadol to an individual. Filed March 25, 1999; approved May 14, 2002. Dr. Keck has received no financial gain from this patent. Dr. Guerdjikova is employed by the University of Cincinnati College of Medicine and is a consultant for Bracket.
This is a review article. No animals were involved.
This is a review article. To the best of our knowledge, all procedures performed in studies described in the review, involving human participants, were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent was obtained from all participants.
- 3.Kessler RC, Berglund PA, Chiu WT, Deitz AC, Hudson JI, Shahly V, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Benjet C, Bruffaerts R, de Girolamo G, de Graaf R, Maria Haro J, Kovess-Masfety V, O’Neill S, Posada-Villa J, Sasu C, Scott K, Viana MC, Xavier M (2013) The prevalence and correlates of binge eating disorder in the World health organization world mental health surveys. Biol Psychiatry 73(9):904–914. doi: 10.1016/j.biopsych.2012.11.0204 CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Sonneville KR, Horton NJ, Micali N, Crosby RD, Swanson SA, Solmi F, Field AE (2013) Longitudinal associations between binge eating and overeating and adverse outcomes among adolescents and young adults: does loss of control matter? JAMA Ped 167(2):149–155. doi: 10.1001/2013.jamapediatrics.12 CrossRefGoogle Scholar
- 9.Bellows BK, DuVall SL, Kamauu AW, Supina D, Babcock T, LaFleur J (2015) Healthcare costs and resource utilization of patients with binge-eating disorder and eating disorder not otherwise specified in the department of veterans affairs. Int J Eat Disord 48(8):1082–1091. doi: 10.1002/eat.22427 CrossRefPubMedGoogle Scholar
- 19.Alonso J, de Jonge P, Lim CC, Aguilar-Gaxiola S, Bruffaerts R, Caldas-de-Almeida JM, Liu Z, O’Neill S, Stein DJ, Viana MC, Al-Hamzawi AO, Angermeyer MC, Borges G, Ciutan M, de Girolamo G, Fiestas F, Haro JM, Hu C, Kessler RC, Lepine JP, Levinson D, Nakamura Y, Posada-Villa J, Wojtyniak BJ, Scott KM (2014) Association between mental disorders and subsequent adult onset asthma. J Psychiatr Res 59:179–188. doi: 10.1016/j.jpsychires.2014.09.007 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.de Jonge P, Alonso J, Stein DJ, Kiejna A, Aguilar-Gaxiola S, Viana MC, Liu Z, O’Neill S, Bruffaerts R, Caldas-de-Almeida JM, Lepine JP, Matschinger H, Levinson D, de Girolamo G, Fukao A, Bunting B, Haro JM, Posada-Villa JA, Al-Hamzawi AO, Medina-Mora ME, Piazza M, Hu C, Sasu C, Lim CC, Kessler RC, Scott KM (2014) Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression. Diabetologia 57(4):699–709. doi: 10.1007/s00125-013-3157-9 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Stein DJ, Aguilar-Gaxiola S, Alonso J, Bruffaerts R, de Jonge P, Liu Z, Miguel Caldas-de-Almeida J, O’Neill S, Viana MC, Al-Hamzawi AO, Angermeyer MC, Benjet C, de Graaf R, Ferry F, Kovess-Masfety V, Levinson D, de Girolamo G, Florescu S, Hu C, Kawakami N, Maria Haro J, Piazza M, Posada-Villa J, Wojtyniak BJ, Xavier M, Lim CC, Kessler RC, Scott KM (2014) Associations between mental disorders and subsequent onset of hypertension. Gen Hosp Psychiatry 36(2):142–149. doi: 10.1016/j.genhosppsych.2013.11.002 CrossRefPubMedGoogle Scholar
- 32.Barber JA, Schumann KP, Foran-Tuller KA, Islam LZ, Barnes RD (2015) Medication use and metabolic syndrome among overweight/obese patients with and without binge-eating disorder in a primary care sample. Prim Care Companion CNS Disord. doi: 10.4088/PCC.15m01816 CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Udo T, White MA, Lydecker JL, Barnes RD, Genao I, Garcia R, Masheb RM, Grilo CM (2016) Biopsychosocial correlates of binge eating disorder in Caucasian and African American women with obesity in primary care settings. Eur Eat Disord Rev 24(3):181–186. doi: 10.1002/erv.2417 CrossRefPubMedGoogle Scholar
- 36.Blomquist KK, Milsom VA, Barnes RD, Boeka AG, White MA, Masheb RM, Grilo CM (2012) Metabolic syndrome in obese men and women with binge eating disorder: developmental trajectories of eating and weight-related behaviors. Compr Psychiatry 53(7):1021–1027. doi: 10.1016/j.comppsych.2012.02.006 CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Barnes RD, Boeka AG, McKenzie KC, Genao I, Garcia RL, Ellman MS, Ellis PJ, Masheb RM, Grilo CM (2011) Metabolic syndrome in obese patients with binge-eating disorder in primary care clinics: a cross-sectional study. Prim Care Companion CNS Disord. doi: 10.4088/PCC.10m01050 CrossRefPubMedPubMedCentralGoogle Scholar
- 40.Mitchell JE, King WC, Pories W, Wolfe B, Flum DR, Spaniolas K, Bessler M, Devlin M, Marcus MD, Kalarchian M, Engel S, Khandelwal S, Yanovski S (2015) Binge eating disorder and medical comorbidities in bariatric surgery candidates. Int J Eat Disord 48(5):471–476. doi: 10.1002/eat.22389 CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Rosenbaum DL, Kimerling R, Pomernacki A, Goldstein KM, Yano EM, Sadler AG, Carney D, Bastian LA, Bean-Mayberry BA, Frayne SM (2016) Binge eating among women veterans in primary care: comorbidities and treatment priorities. Womens Health Issues. doi: 10.1016/j.whi.2016.02.004 CrossRefPubMedGoogle Scholar
- 42.Lourenco BH, Arthur T, Rodrigues MD, Guazzelli I, Frazzatto E, Deram S, Nicolau CY, Halpern A, Villares SM (2008) Binge eating symptoms, diet composition and metabolic characteristics of obese children and adolescents. Appetite 50(2–3):223–230. doi: 10.1016/j.appet.2007.07.004 CrossRefPubMedGoogle Scholar
- 47.Hudson JI, Lalonde JK, Coit CE, Tsuang MT, McElroy SL, Crow SJ, Bulik CM, Hudson MS, Yanovski JA, Rosenthal NE, Pope HG (2010) Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge eating disorder. Am J Clin Nutrition 91(6):1568–1573CrossRefGoogle Scholar
- 51.Celik S, Kayar Y, Onem Akcakaya R, Turkyilmaz Uyar E, Kalkan K, Yazisiz V, Aydin C, Yucel B (2015) Correlation of binge eating disorder with level of depression and glycemic control in type 2 diabetes mellitus patients. Gen Hosp Psychiatry 37(2):116–119. doi: 10.1016/j.genhosppsych.2014.11.012 CrossRefPubMedGoogle Scholar
- 53.Gorin AA, Niemeier HM, Hogan P, Coday M, Davis C, DiLillo VG, Gluck ME, Wadden TA, West DS, Williamson D, Yanovski SZ, Look ARG (2008) Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: results from the look ahead trial. Arch Gen Psychiatry 65(12):1447–1455. doi: 10.1001/archpsyc.65.12.1447 CrossRefPubMedPubMedCentralGoogle Scholar
- 58.Mannucci E, Tesi F, Ricca V, Pierazzuoli E, Barciulli E, Moretti S, Di Bernardo M, Travaglini R, Carrara S, Zucchi T, Placidi GF, Rotella CM (2002) Eating behavior in obese patients with and without type 2 diabetes mellitus. Int J Obes Relat Metab Disord 26(6):848–853. doi: 10.1038/sj.ijo.0801976 CrossRefPubMedGoogle Scholar
- 61.Today Study Group, Wilfley D, Berkowitz R, Goebel-Fabbri A, Hirst K, Ievers-Landis C, Lipman TH, Marcus M, Ng D, Pham T, Saletsky R, Schanuel J, Van Buren D (2011) Binge eating, mood, and quality of life in youth with type 2 diabetes: baseline data from the today study. Diabetes Care 34(4):858–860. doi: 10.2337/dc10-1704 CrossRefGoogle Scholar
- 65.Takii M, Uchigata Y, Tokunaga S, Amemiya N, Kinukawa N, Nozaki T, Iwamoto Y, Kubo C (2008) The duration of severe insulin omission is the factor most closely associated with the microvascular complications of type 1 diabetic females with clinical eating disorders. Int J Eat Disord 41(3):259–264. doi: 10.1002/eat.20498 CrossRefPubMedGoogle Scholar
- 66.Smith FM, Latchford GJ, Hall RM, Dickson RA (2008) Do chronic medical conditions increase the risk of eating disorder? A cross-sectional investigation of eating pathology in adolescent females with scoliosis and diabetes. J Adolesc Health 42(1):58–63. doi: 10.1016/j.jadohealth.2007.08.008 CrossRefPubMedGoogle Scholar
- 77.Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG (2000) Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis risk in communities. Circulation 102(11):1239–1244CrossRefGoogle Scholar
- 79.Lelli L, Rotella F, Castellini G, Benni L, Lo Sauro C, Barletta G, Mannucci E, Castellani S, Di Tante V, Galanti G, Ricca V (2015) Echocardiographic findings in patients with eating disorders: a case-control study. Nutr Metab Cardiovasc Dis 25(7):694–696. doi: 10.1016/j.numecd.2015.04.004 CrossRefPubMedGoogle Scholar
- 85.Brownley KA, Von Holle A, Hamer RM, La Via M, Bulik CM (2013) A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study. J Psychosom Res 75(1):36–42. doi: 10.1016/j.jpsychores.2013.03.092 CrossRefPubMedPubMedCentralGoogle Scholar
- 87.American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, WashingtonGoogle Scholar